Keep Current with the Latest in Cell Biology Research

Engineered CD47 Protects T Cells for Enhanced Antitumour Immunity

[Nature] Researchers administered anti-CD47 antibodies in combination with adoptively transferred T cells with the goal of enhancing antitumour efficacy but observed abrogated therapeutic benefit due to rapid macrophage-mediated clearance of T cells expressing CARs or engineered T cell receptors.

CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy against Solid Tumor

[Small] A CAR T cell membrane-camouflaged nanocatalyst (ACSP@TCM) was prepared to augment CAR T cell therapy efficacy against solid tumors. ACSP@TCM was prepared by encapsulating core/shell Au/Cu2-xSe and 3-bromopyruvate with a CAR T cell membrane.

Recommendations for Reporting Tissue and Circulating Tumor (ct)DNA Next-Generation Sequencing Results in Non-Small Cell Lung Cancer

[British Journal Of Cancer] Scientists discuss next-generation sequencing workflows, the structure of next-generation sequencing reports, and our recommendations for best practice thereof.

GPC3-Targeted CAR-T Cells Expressing GLUT1 or AGK Exhibit Enhanced Antitumor Activity against Hepatocellular Carcinoma

[Acta Pharmacologica Sinica] The authors generated GPC3-targeted CAR-T cells overexpressing GLUT1 or AGK for the treatment of HCC. GPC3-targeted CAR-T cells overexpressing GLUT1 or AGK specifically and effectively lysed GPC3-positive tumor cells in vitro in an antigen-dependent manner.

SMYD2 Induced PGC1α Methylation Promotes Stemness Maintenance of Glioblastoma Stem Cells

[Neuro-Oncology] SMYD2-induced PGC1α methylation and followed nuclear export was confirmed by co-immunoprecipitation, cellular fractionation, and immunofluorescence.

Targeting NKG2D Ligands in Glioblastoma with a Bispecific T-Cell Engager Is Augmented with Conventional Therapy and Enhances Oncolytic Virotherapy of Glioma Stem-Like Cells

[Journal For Immunotherapy Of Cancer] Researchers designed a bispecific T cell engager capable of cross-linking CD3 on T cells with NKG2DL-expressing GBM cells. They then engineered the G207 virus to express the NKG2D BiTE and secrete it from infected cells.

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase II Randomized, Clinical Trial...

[Intensity Therapeutics, Inc.] Intensity Therapeutics, Inc. announced that the company executed a collaboration agreement with The Swiss Group for Clinical Cancer Research SAKK to conduct a Phase II randomized, controlled trial evaluating clinical and biological effects of intratumoral INT230-6 followed by the standard of care (SOC) immuno/chemotherapy vs. SOC immune/chemotherapy alone in early-stage triple-negative breast cancer in 54 patients in Switzerland.

Nucleoporin 93 Regulates Cancer Cell Growth and Stemness in Bladder Cancer via Wnt/β-Catenin Signaling

[Molecular Biotechnology] BLCA cells were used to investigate the effects of Nup93 overexpression or knockdown on cell growth, invasion, stemness , and Wnt/β-catenin signaling in vitro.

Synergistic Antitumor Activity by Dual Blockade of CCR1 and CXCR2 Expressed on Myeloid Cells within the Tumor Microenvironment

[British Journal Of Cancer] Investigators generated double-knockout mice for CCR1 and CXCR2, and performed bone marrow transfer experiments in which sub-lethally irradiated wild-type mice were reconstituted with bone marrow from either wild-type, Ccr1−/−, Cxcr2−/− or Ccr1−/−Cxcr2−/− mice.

Confined Bioprinting and Culture in Inflatable Bioreactor for the Sterile Bioproduction of Tissues and Organs

[Scientific Reports] The authors introduced a novel device called the Flexible Unique Generator Unit, which is a unique combination of flexible silicone membranes and solid components made of stainless steel.

Navigating the Tumor Microenvironment: Mesenchymal Stem Cell-Mediated Delivery of Anticancer Agents

[Journal Of Drug Targeting] The authors elaborates on recent advancements of mesenchyma stem cell mediated drug delivery of anti-cancer agents along with its mechanism and previously reported studies of drugs manufactured via this drug delivery system.

Hepatocytes Differentiate Into Intestinal Epithelial Cells Through a Hybrid Epithelial/Mesenchymal Cell State in Culture

[Nature Communications] Investigators employed a culture system specifically established for hepatic progenitor cells to study hepatocyte dedifferentiation.

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

spot_img